Feb 21, 2024 / 08:00PM GMT
Yigal Nochomovitz - Citi - Analyst
Great. Welcome, everyone. Thanks for sticking with us through the afternoon hours of our first day of the Virtual Oncology Leadership Summit. As you know, I'm Yigal Nochomovitz, that's one of the biotech analyst here at Citigroup. (Conference Instructions)
So with that, it's my great pleasure to have with me senior leadership on ORIC, Jacob Chacko, the CEO; Dominic Piscitelli, CFO; Pratik Multani, the CMO. So thank you all so much for taking the time. It's a story than a lot of the people listening are familiar with.
Questions and Answers:
Yigal Nochomovitz - Citi - AnalystBut nonetheless, Jacob, I think helpful to set the stage for us. Give us a quick sense of the pipeline. What are the key priorities for the company over the course of 2024?
Jacob Chacko - ORIC Pharmaceuticals, Inc. - President, CEO & Board Member
Sure. Thank you for having, Yigal. I think most folks are well familiar with the pipeline, so I keep my introductory comments quite quick. We are a
Trustpilot
